WPA
TNXP icon

Wealth Preservation Advisors’s Tonix Pharmaceuticals TNXP Stock Holding History

Wealth Preservation Advisors’s Portfolio TNXP Stock Details TNXP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$756 Buy
+55
New +$847 ﹤0.01% 724

Other funds holding TNXP

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
JHC
Jones Hill Capital New York $466M AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Wealth Preservation Advisors's TNXP Position: Q1 2026 in Review

Wealth Preservation Advisors opened a new position in Tonix Pharmaceuticals (TNXP) in Q1 2026: 55 shares worth $756. The stake represents ﹤0.01% of the portfolio and ranks #724 among its holdings.

81 funds tracked by Wall St. Rank hold TNXP as of Q1 2026.

  • Wealth Preservation Advisors held 55 shares of Tonix Pharmaceuticals worth $756 as of Q1 2026.
  • Tonix Pharmaceuticals was a new Wealth Preservation Advisors position in Q1 2026.
  • Tonix Pharmaceuticals made up ﹤0.01% of Wealth Preservation Advisors's portfolio in Q1 2026, its #724 holding.
  • 81 funds tracked by Wall St. Rank held Tonix Pharmaceuticals as of Q1 2026.

Based on Wealth Preservation Advisors's 13F filing for Q1 2026, filed 15 May 2026.